Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas

☆ Author's contribution to manuscript: Dr. Gialafos E: manuscript. Kokotis P. — Acquisition and interpretation tests. Andreadou E., Evangelopoulos ME., Filippatos G., H C. — Critical revision of the manuscript. Anagnostouli M. — ☆☆ Financial disclosure statement: Giallafos E, Kokkotis P Evangelopoulos received research grant from Biogen, No ceived research grants from Genesis Pharma and Teva. Co and honoraria from Genzyme, Genesis Pharma, Teva an Merck Serono, Novartis, Teva and Genesis Pharma. E. Andr from Biogen, Merck-Serono, Novartis, and SanofiAventis a G. Filippatos is a member of the executive committee o Cardiorentis and Bayer. C. Kilidireas received research Teva, and Merck-Serono. M. Anagnostouli received resea Serono, Novartis, Teva, Bayer and Genzyme as well as le Biogen and Genzyme. ⁎ Corresponding author at: Ipsilantou 37, Kolonaki, 106 E-mail address: gialaf@yahoo.com (E. Gialafos).